Vinge has advised Nordic Nest Group AB, a company within the BHG Group, in connection the asset acquisition of KitchenTime’s brand and inventory for a total price of up to SEK 65 million. Closing is estimated to take place on 1 april 2024.
Vinge has advised Attendo, the largest care company in the Nordic region, in connection with the conclusion of an agreement to acquire Team Olivia's Swedish care operations (excluding personal assistance). Attendo thereby strengthens its position within care for people with disabilities, individual and family care as well as home care in Sweden.
Vinge advises Santander Consumer Finance in connection with its acquisition of all shares in Athlon Sweden AB, which is part of Mercedes-Benz Mobility.
Vinge advises EQT Healthcare Growth, a new dedicated healthcare buy-out strategy introduced by EQT, in connection with its first investment – the acquisition of the biotech company, Mabtech, from IK Small Cap II Fund and several minority sellers.
Lantmännen has signed an agreement to acquire HKScan Corporation’s Swedish operations, HKScan Sweden AB. The acquisition includes all operations in Sweden and the brands Scan, Pärsons and Bullens. The acquisition means that Lantmännen is broadening and strengthening its business portfolio from field to fork – and that long-term conditions for Swedish agriculture are strengthened.
Vinges advises the EQT X fund (or “EQT Private Equity”) in connection with its investment in the Nordic software companies HVD Group (Hantverksdata) and Next (Next One Technology). Both companies serve the tradespeople and construction industry, with HVD Group focused on installation and service professions – such as electricians, plumbers, heating and ventilation firms – while Next is focused on contractors. HVD Group’s platform complements that of Next, and the investment thus paves the way for a further strengthened product offering, which builds on both companies’ strong customer satisfaction scores.
Veoneer is the world leader in automotive electronic restraint control systems and has sold more than 1 billion electronic control units and crash sensors. Veoneer’s scalable, best-in-class restraint control systems are saving lives by mitigating the effects of car crashes. In 2023, the company’s products are part of more than 40 scheduled vehicle launches. The company has approximately 2,700 employees in 11 countries.
Due Compliance is a software company which enables organisations to comply with the requirements in relation to Money Laundering and Terrorist Financing (Prevention) Act by providing digital tools for AML, KYC and Risk Assessments.
Caisse de dépôt et placement du Québec (CDPQ) have invested USD 150 million in Northvolt by of a convertible debt instrument. The financing will be used to realize the new site Northvolt Six in Québec. When the battery factory is completed, it will have an annual production capacity of up to 60 GWh.
Vinge has advised Carnegie Investment Bank AB in connection with the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser Corporate Finance as well as the analytical services Penser Access and Penser Future from Erik Penser Bank AB. The consideration for the completed purchase consists of shares in Carnegie and the acquisition is subject to customary conditions from public authorities.
Vinge has advised the Norwegian private equity firm Equip Capital and its portfolio company Remagruppen in connection with the acquisition of Beredningsbart Syd AB (”BNB Syd”).
Vinge advises Fairpoint Capital and eEquity in connection with their investment by participation in a MSEK 90 investment round in Mediatool, a company who provides a digital marketing management platform for brands and media agencies.
Vinge has advised Thermo Fisher Scientific Inc., (”Thermo Fisher”), the world leader in serving science, with annual revenue over $40 billion, in connection with its acquisition of Olink Holding AB (publ) (“Olink”).
Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
